APA aipamena

Ding, T., Zhou, F., Chen, X., Zhang, S., Liu, Y., Sun, H., . . . Zhou, C. (2017). Continuation of gefitinib plus chemotherapy prolongs progression-free survival in advanced non-small cell lung cancer patients who get acquired resistance to gefitinib without T790M mutations. J Thorac Dis.

Chicago Style aipamena

Ding, Ting, et al. "Continuation of Gefitinib Plus Chemotherapy Prolongs Progression-free Survival in Advanced Non-small Cell Lung Cancer Patients Who Get Acquired Resistance to Gefitinib Without T790M Mutations." J Thorac Dis 2017.

MLA aipamena

Ding, Ting, et al. "Continuation of Gefitinib Plus Chemotherapy Prolongs Progression-free Survival in Advanced Non-small Cell Lung Cancer Patients Who Get Acquired Resistance to Gefitinib Without T790M Mutations." J Thorac Dis 2017.